Alessandro Inno

25PUBLICATIONS

146CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPredictive and prognostic markersCancer cell biology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (25)

Sort by Publication Date:

|Jun 15, 2026

Long-term outcomes of ALK inhibitors in metastatic <i>ALK</i>-positive non-small cell lung cancer: an updated indirect comparison using reconstructed patient-level data.

|Feb 27, 2026

<i>PIK3CA</i> Alterations in NSCLC: Clinical Characteristics of a "Neglected" Population of Oncogene-Addicted Patients.

Sabrina Rossi, Arianna Pagliaro, Silvia Masini

|Feb 13, 2026

Chemoimmunotherapy Combinations in Elderly Patients with Metastatic Non-Small Cell Lung Cancer and PD-L1 Expression < 50%: Results from an Italian Real-World Study.

Antonello Veccia, Ettore D'Argento, Floriana Morgillo

|Nov 13, 2025

A New Era, New Risks: The Cardio-Oncology Perspective on Immunotherapy in Non-Small Cell Lung Cancer.

Luigi Tarantini, Giuseppina Gallucci, Alessandro Inno

|Sep 27, 2025

Long-Term Cardiovascular Toxicity of Immunotherapy: Too Important to Ignore.

Andrea Camerini, Alessandro Inno, Maria Laura Canale

|Jul 29, 2025

PCSK9 Inhibitor Inclisiran Attenuates Cardiotoxicity Induced by Sequential Anthracycline and Trastuzumab Exposure via NLRP3 and MyD88 Pathway Inhibition.

Vincenzo Quagliariello, Massimiliano Berretta, Irma Bisceglia

Pageof 5

Frequent Collaborators

8 joint publications

Stefania Gori

6 joint publications

Massimiliano Berretta

Irma Bisceglia

Nicola Maurea

Luigi Tarantini

Domenico Gabrielli

Martina Iovine

Vincenzo Quagliariello

4 joint publications

Alessandro Navazio

3 joint publications

Carmine Pinto

Frequent Collaborators

8 joint publications

Stefania Gori

6 joint publications

Massimiliano Berretta

6 joint publications

Irma Bisceglia

6 joint publications

Nicola Maurea